275 related articles for article (PubMed ID: 26051797)
21. Analysis of clinical outcome and survival in pediatric patients undergoing extracorporeal photopheresis for the treatment of steroid-refractory GVHD.
González Vicent M; Ramirez M; Sevilla J; Abad L; Díaz MA
J Pediatr Hematol Oncol; 2010 Nov; 32(8):589-93. PubMed ID: 20962677
[TBL] [Abstract][Full Text] [Related]
22. Modulation of lymphocyte subpopulations by extracorporeal photopheresis in patients with acute graft-versus-host disease or graft rejection.
Lorenz K; Rommel K; Mani J; Jin N; Hilgendorf I; Ho AD; Freund M; Schmitt M; Schmitt A
Leuk Lymphoma; 2015 Mar; 56(3):671-5. PubMed ID: 24913503
[TBL] [Abstract][Full Text] [Related]
23. The role of extracorporeal photopheresis in the management of cutaneous T-cell lymphoma, graft-versus-host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society.
Alfred A; Taylor PC; Dignan F; El-Ghariani K; Griffin J; Gennery AR; Bonney D; Das-Gupta E; Lawson S; Malladi RK; Douglas KW; Maher T; Guest J; Hartlett L; Fisher AJ; Child F; Scarisbrick JJ
Br J Haematol; 2017 Apr; 177(2):287-310. PubMed ID: 28220931
[TBL] [Abstract][Full Text] [Related]
24. Response of steroid-refractory chronic graft-versus-host disease to extracorporeal photopheresis correlates with the dose of CD3+ lymphocytes harvested during early treatment cycles.
Bertani G; Santoleri L; Ferri U; Marenco P; Grillo G; Zucchetti E; Forno B; Lando G; Scarpati B; Cairoli R; Rossini S; Cesana C
Transfusion; 2016 Feb; 56(2):505-10. PubMed ID: 26453579
[TBL] [Abstract][Full Text] [Related]
25. Updating ECP action mechanisms.
Heshmati F
Transfus Apher Sci; 2014 Jun; 50(3):330-9. PubMed ID: 24837416
[TBL] [Abstract][Full Text] [Related]
26. Extracorporeal photopheresis: a useful therapy for patients with steroid-refractory acute graft-versus-host disease but not for the prevention of the chronic form.
Rubegni P; Feci L; Poggiali S; Marotta G; D'Ascenzo G; Murdaca F; Fimiani M
Br J Dermatol; 2013 Aug; 169(2):450-7. PubMed ID: 23534380
[TBL] [Abstract][Full Text] [Related]
27. Extracorporeal photopheresis in pediatric patients: Practical and technical considerations.
DeSimone RA; Schwartz J; Schneiderman J
J Clin Apher; 2017 Dec; 32(6):543-552. PubMed ID: 28304115
[TBL] [Abstract][Full Text] [Related]
28. Treatment of graft versus host disease (GVHD) by photopheresis?
Schooneman F; Claise C
Transfus Sci; 1996 Dec; 17(4):527-36. PubMed ID: 10168550
[TBL] [Abstract][Full Text] [Related]
29. Update on the mechanism of action and on clinical efficacy of extracorporeal photopheresis in the treatment of acute and chronic graft versus host disease in children.
Goussetis E; Varela I; Tsirigotis P
Transfus Apher Sci; 2012 Apr; 46(2):203-9. PubMed ID: 22079263
[TBL] [Abstract][Full Text] [Related]
30. Early reduction in number of T cells producing proinflammatory cytokines, observed after extracorporeal photopheresis, is not linked to apoptosis induction.
Bladon J; Taylor PC
Transplant Proc; 2003 Jun; 35(4):1328-32. PubMed ID: 12826151
[TBL] [Abstract][Full Text] [Related]
31. [Advances of mechanism study on extracorporeal photochemotherapy to treat and prevent graft-versus-host disease in vitro--review].
Chen Z; Zhao G; Chen BA
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1376-80. PubMed ID: 21129297
[TBL] [Abstract][Full Text] [Related]
32. Maturation state of dendritic cells during the extracorporeal photopheresis and its relevance for the treatment of chronic graft-versus-host disease.
Spisek R; Gasova Z; Bartunkova J
Transfusion; 2006 Jan; 46(1):55-65. PubMed ID: 16398731
[TBL] [Abstract][Full Text] [Related]
33. Extracorporeal photopheresis in prevention and treatment of acute GVHD.
Kitko CL; Levine JE
Transfus Apher Sci; 2015 Apr; 52(2):151-6. PubMed ID: 25748231
[TBL] [Abstract][Full Text] [Related]
34. Extracorporeal photopheresis: technique, established and novel indications.
Marques MB; Adamski J
J Clin Apher; 2014 Aug; 29(4):228-34. PubMed ID: 24828404
[TBL] [Abstract][Full Text] [Related]
35. Extracorporeal photopheresis in cutaneous T-cell lymphoma and graft-versus-host disease induces both immediate and progressive apoptotic processes.
Bladon J; Taylor PC
Br J Dermatol; 2002 Jan; 146(1):59-68. PubMed ID: 11841367
[TBL] [Abstract][Full Text] [Related]
36. Cryopreserved ECP-treated lymphocytes maintain apoptotic response and anti-proliferative effect.
Radwanski K; Heber C; Min K
J Clin Apher; 2015 Jun; 30(3):154-61. PubMed ID: 25213780
[TBL] [Abstract][Full Text] [Related]
37. A Prospective Trial of Extracorporeal Photopheresis for Chronic Graft-versus-Host Disease Reveals Significant Disease Response and No Association with Frequency of Regulatory T Cells.
Gandelman JS; Song DJ; Chen H; Engelhardt BG; Chen YB; Clark WB; Giver CR; Waller EK; Jung DK; Jagasia M
Biol Blood Marrow Transplant; 2018 Dec; 24(12):2373-2380. PubMed ID: 29981848
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and immunologic effects of extracorporeal photopheresis plus interleukin-2 in chronic graft-versus-host disease.
Belizaire R; Kim HT; Poryanda SJ; Mirkovic NV; Hipolito E; Savage WJ; Reynolds CG; Fields MJ; Whangbo J; Kubo T; Nikiforow S; Alyea EP; Armand P; Cutler CS; Ho VT; Blazar BR; Antin JH; Ritz J; Soiffer RJ; Koreth J
Blood Adv; 2019 Apr; 3(7):969-979. PubMed ID: 30936057
[TBL] [Abstract][Full Text] [Related]
39. Extracorporeal photochemotherapy.
Maeda A
J Dermatol Sci; 2009 Jun; 54(3):150-6. PubMed ID: 19369039
[TBL] [Abstract][Full Text] [Related]
40. ECP and solid organ transplantation.
Jaksch P; Knobler R
Transfus Apher Sci; 2014 Jun; 50(3):358-62. PubMed ID: 24768429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
